How to buy Monash IVF Group (MVF) shares in Australia
Learn how to easily invest in Monash IVF Group shares.
Monash IVF Group is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Monash IVF Group has a trailing 12-month revenue of around $213.6 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Monash IVF Group
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Monash IVF Group. Find the share by name or ticker symbol: MVF. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Monash IVF Group reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Monash IVF Group. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
What's in this guide?
- Monash IVF Group key stats
- Compare share trading platforms
- Is Monash IVF Group stock a buy or sell?
- Monash IVF Group performance over time
- Are Monash IVF Group shares over-valued?
- Monash IVF Group's financials
- How volatile are Monash IVF Group shares?
- Does Monash IVF Group pay a dividend?
- Other common questions
Monash IVF Group stock price (ASX:MVF)Use our graph to track the performance of MVF stocks over time.
Monash IVF Group shares at a glance
|52-week range||$0.8889 - $1.32|
|50-day moving average||$1.2808|
|200-day moving average||$1.1718|
|Dividend yield||$0.044 (3.52%)|
|Earnings per share (TTM)||$0.06|
Compare share trading platforms
Is it a good time to buy Monash IVF Group stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Monash IVF Group price performance over time
|1 week (2023-11-24)||4.00%|
|1 month (2023-11-02)||-0.76%|
|3 months (2023-09-01)||3.17%|
|6 months (2023-06-02)||13.04%|
|1 year (2022-12-02)||30.65%|
|2 years (2021-12-02)||41.30%|
|3 years (2020-12-02)||78.08%|
|5 years (2018-11-30)||36.84%|
Is Monash IVF Group under- or over-valued?
Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Monash IVF Group's P/E ratio
Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 22x. In other words, Monash IVF Group shares trade at around 22x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Monash IVF Group's EBITDA
Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $40.4 million (£0.0 million).
The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure a its profitability.
Monash IVF Group financials
|Revenue TTM||$213.6 million|
|Operating margin TTM||16.9%|
|Gross profit TTM||$72.8 million|
|Return on assets TTM||5.45%|
|Return on equity TTM||8.06%|
|Market capitalisation||$498.7 million|
TTM: trailing 12 months
Monash IVF Group share dividends
Dividend payout ratio: 146.67% of net profits
Recently Monash IVF Group has paid out, on average, around 146.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 3.52% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.044 per share.
Monash IVF Group's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 7 September 2023 (the "ex-dividend date").
Monash IVF Group share price volatility
Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $0.8889 up to $1.32. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.468. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively speaking, a higher risk (but potentially also market-beating returns).
Monash IVF Group overview
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.
Stocks similar to Monash IVF Group
Monash IVF Group in the news
Frequently asked questions
More guides on Finder
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert